{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:18:46Z","timestamp":1790968726113,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Henan Provincial Medical Science and Technology Research Plan Provincial and Ministerial Joint Construction Major Project","award":["No.SBGJ202001009"],"award-info":[{"award-number":["No.SBGJ202001009"]}]},{"name":"2022 Major Science and Technology Project of Henan Province","award":["No.221100310200"],"award-info":[{"award-number":["No.221100310200"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-25904-6","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:54:44Z","timestamp":1764082484000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A novel sulfonamide derivative suppresses gastrointestinal cancer progression by targeting Axin2 and \u03b2-catenin"],"prefix":"10.1038","volume":"15","author":[{"given":"Xiaojie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayuan","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengke","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"25904_CR1","doi-asserted-by":"publisher","unstructured":"Arnold, M. et al. Global Burden of 5 major types of gastrointestinal cancer. Gastroenterology 159, 335\u2013349 e315, (2020). https:\/\/doi.org\/10.1053\/j.gastro.2020.02.068","DOI":"10.1053\/j.gastro.2020.02.068"},{"key":"25904_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41575-022-00726-3","volume":"20","author":"J Huang","year":"2023","unstructured":"Huang, J. et al. Updated epidemiology of gastrointestinal cancers in East Asia. Nat. Rev. Gastroenterol. Hepatol. 20, 271\u2013287. https:\/\/doi.org\/10.1038\/s41575-022-00726-3 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"25904_CR3","doi-asserted-by":"publisher","first-page":"101404","DOI":"10.1016\/j.eclinm.2022.101404","volume":"47","author":"E Morgan","year":"2022","unstructured":"Morgan, E. et al. The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: A population-based modelling study. EClinicalMedicine 47, 101404. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101404 (2022).","journal-title":"EClinicalMedicine"},{"key":"25904_CR4","doi-asserted-by":"publisher","unstructured":"Kuipers, E. J. et al. Colorectal cancer. Nat. Rev. Dis. Primers. 1 https:\/\/doi.org\/10.1038\/nrdp.2015.65 (2015).","DOI":"10.1038\/nrdp.2015.65"},{"key":"25904_CR5","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s10555-020-09925-3","volume":"39","author":"RE Sexton","year":"2020","unstructured":"Sexton, R. E., Hallak, A., Diab, M. N., Azmi, A. S. & M. & Gastric cancer: A comprehensive review of current and future treatment strategies. Cancer Metastasis Rev. 39, 1179\u20131203. https:\/\/doi.org\/10.1007\/s10555-020-09925-3 (2020).","journal-title":"Cancer Metastasis Rev."},{"key":"25904_CR6","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1016\/j.apsb.2021.03.008","volume":"11","author":"S He","year":"2021","unstructured":"He, S., Xu, J., Liu, X. & Zhen, Y. Advances and challenges in the treatment of esophageal cancer. Acta Pharm. Sin B. 11, 3379\u20133392. https:\/\/doi.org\/10.1016\/j.apsb.2021.03.008 (2021).","journal-title":"Acta Pharm. Sin B"},{"key":"25904_CR7","unstructured":"Bryant, B. K. K. Pharmacology for Health Professionals 3rd Edition. Vol. 3 645 (2011)."},{"key":"25904_CR8","doi-asserted-by":"publisher","first-page":"113837","DOI":"10.1016\/j.ejmech.2021.113837","volume":"226","author":"Y Wan","year":"2021","unstructured":"Wan, Y., Fang, G., Chen, H., Deng, X. & Tang, Z. Sulfonamide derivatives as potential anti-cancer agents and their SARs Elucidation. Eur. J. Med. Chem. 226, 113837. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113837 (2021).","journal-title":"Eur. J. Med. Chem."},{"key":"25904_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s12551-021-00795-9","volume":"13","author":"A Ovung","year":"2021","unstructured":"Ovung, A. & Bhattacharyya, J. Sulfonamide drugs: Structure, antibacterial property, toxicity, and biophysical interactions. Biophys. Rev. 13, 259\u2013272. https:\/\/doi.org\/10.1007\/s12551-021-00795-9 (2021).","journal-title":"Biophys. Rev."},{"key":"25904_CR10","doi-asserted-by":"publisher","first-page":"100609","DOI":"10.1016\/j.mcpro.2023.100609","volume":"22","author":"DP O\u2019Brien","year":"2023","unstructured":"O\u2019Brien, D. P. et al. Structural premise of selective deubiquitinase USP30 inhibition by small-molecule benzosulfonamides. Mol. Cell. Proteom. 22, 100609. https:\/\/doi.org\/10.1016\/j.mcpro.2023.100609 (2023).","journal-title":"Mol. Cell. Proteom."},{"key":"25904_CR11","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.ejmech.2016.10.020","volume":"124","author":"MM Ghorab","year":"2016","unstructured":"Ghorab, M. M., Alsaid, M. S., Al-Ansary, G. H. & Abdel-Latif, G. A. Abou El Ella, D. A. Analogue based drug design, synthesis, molecular docking and anticancer evaluation of novel chromene sulfonamide hybrids as aromatase inhibitors and apoptosis enhancers. Eur. J. Med. Chem. 124, 946\u2013958. https:\/\/doi.org\/10.1016\/j.ejmech.2016.10.020 (2016).","journal-title":"Eur. J. Med. Chem."},{"key":"25904_CR12","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ejmech.2017.04.069","volume":"135","author":"KO Mohamed","year":"2017","unstructured":"Mohamed, K. O. et al. Design, synthesis and biological evaluation of some novel sulfonamide derivatives as apoptosis inducers. Eur. J. Med. Chem. 135, 424\u2013433. https:\/\/doi.org\/10.1016\/j.ejmech.2017.04.069 (2017).","journal-title":"Eur. J. Med. Chem."},{"key":"25904_CR13","doi-asserted-by":"publisher","first-page":"27540","DOI":"10.1038\/srep27540","volume":"6","author":"CH Wu","year":"2016","unstructured":"Wu, C. H. et al. Pharmacological exploitation of the phenothiazine antipsychotics to develop novel antitumor agents-A drug repurposing strategy. Sci. Rep. 6, 27540. https:\/\/doi.org\/10.1038\/srep27540 (2016).","journal-title":"Sci. Rep."},{"key":"25904_CR14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00044-015-1482-x","volume":"25","author":"S Maddila","year":"2016","unstructured":"Maddila, S. et al. Novel 2-(1-(substitutedbenzyl)-1H-tetrazol-5-yl)-3-phenylacrylonitrile derivatives: Synthesis, in vitro antitumor activity and computational studies. Med. Chem. Res. 25, 283\u2013291. https:\/\/doi.org\/10.1007\/s00044-015-1482-x (2016).","journal-title":"Med. Chem. Res."},{"key":"25904_CR15","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.ejmech.2018.11.017","volume":"162","author":"C Zhao","year":"2019","unstructured":"Zhao, C., Rakesh, K. P., Ravidar, L., Fang, W. Y. & Qin, H. L. Pharmaceutical and medicinal significance of sulfur (S(VI))-containing motifs for drug discovery: A critical review. Eur. J. Med. Chem. 162, 679\u2013734. https:\/\/doi.org\/10.1016\/j.ejmech.2018.11.017 (2019).","journal-title":"Eur. J. Med. Chem."},{"key":"25904_CR16","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1517\/13543776.10.11.1725","volume":"10","author":"T Owa","year":"2005","unstructured":"Owa, T. & Nagasu, T. Novel sulphonamide derivatives for the treatment of cancer. Expert Opin. Ther. Pat. 10, 1725\u20131740. https:\/\/doi.org\/10.1517\/13543776.10.11.1725 (2005).","journal-title":"Expert Opin. Ther. Pat."},{"key":"25904_CR17","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1016\/j.bmcl.2019.06.041","volume":"29","author":"S Apaydin","year":"2019","unstructured":"Apaydin, S. & Torok, M. Sulfonamide derivatives as multi-target agents for complex diseases. Bioorg. Med. Chem. Lett. 29, 2042\u20132050. https:\/\/doi.org\/10.1016\/j.bmcl.2019.06.041 (2019).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"25904_CR18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ejmech.2014.10.070","volume":"89","author":"M Jelen","year":"2015","unstructured":"Jelen, M. et al. 6-Substituted 9-fluoroquino[3,2-b]benzo[1,4]thiazines display strong antiproliferative and antitumor properties. Eur. J. Med. Chem. 89, 411\u2013420. https:\/\/doi.org\/10.1016\/j.ejmech.2014.10.070 (2015).","journal-title":"Eur. J. Med. Chem."},{"key":"25904_CR19","doi-asserted-by":"publisher","unstructured":"Angeli, A. et al. Carbonic anhydrase inhibitors targeting metabolism and tumor microenvironment. Metabolites 10 https:\/\/doi.org\/10.3390\/metabo10100412 (2020).","DOI":"10.3390\/metabo10100412"},{"key":"25904_CR20","doi-asserted-by":"publisher","first-page":"6630","DOI":"10.1021\/acs.jmedchem.5b00845","volume":"58","author":"BP Mahon","year":"2015","unstructured":"Mahon, B. P. et al. Mapping selective Inhibition of the cancer-related carbonic anhydrase IX using structure-activity relationships of glucosyl-based sulfamates. J. Med. Chem. 58, 6630\u20136638. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00845 (2015).","journal-title":"J. Med. Chem."},{"key":"25904_CR21","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/pcmr.12495","volume":"29","author":"I Bohme","year":"2016","unstructured":"Bohme, I. & Bosserhoff, A. K. Acidic tumor microenvironment in human melanoma. Pigment Cell. Melanoma Res. 29, 508\u2013523. https:\/\/doi.org\/10.1111\/pcmr.12495 (2016).","journal-title":"Pigment Cell. Melanoma Res."},{"key":"25904_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41388-024-03242-7","volume":"44","author":"J Wang","year":"2025","unstructured":"Wang, J. et al. Targeting RBM39 suppresses tumor growth and sensitizes osteosarcoma cells to cisplatin. Oncogene 44, 575\u2013586. https:\/\/doi.org\/10.1038\/s41388-024-03242-7 (2025).","journal-title":"Oncogene"},{"key":"25904_CR23","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1158\/1535-7163.MCT-17-0139","volume":"16","author":"S Zeng","year":"2017","unstructured":"Zeng, S. et al. Wnt\/beta-catenin signaling contributes to tumor malignancy and is targetable in gastrointestinal stromal tumor. Mol. Cancer Ther. 16, 1954\u20131966. https:\/\/doi.org\/10.1158\/1535-7163.MCT-17-0139 (2017).","journal-title":"Mol. Cancer Ther."},{"key":"25904_CR24","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature11252","volume":"487","author":"Cancer Genome Atlas, N","year":"2012","unstructured":"Cancer Genome Atlas, N. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330\u2013337. https:\/\/doi.org\/10.1038\/nature11252 (2012).","journal-title":"Nature"},{"key":"25904_CR25","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1053\/j.gastro.2011.12.001","volume":"142","author":"BD White","year":"2012","unstructured":"White, B. D., Chien, A. J. & Dawson, D. W. Dysregulation of Wnt\/beta-catenin signaling in gastrointestinal cancers. Gastroenterology 142, 219\u2013232. https:\/\/doi.org\/10.1053\/j.gastro.2011.12.001 (2012).","journal-title":"Gastroenterology"},{"key":"25904_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/carcin\/bgw005","volume":"37","author":"P Pai","year":"2016","unstructured":"Pai, P., Rachagani, S., Dhawan, P. & Batra, S. K. Mucins and Wnt\/beta-catenin signaling in gastrointestinal cancers: An unholy nexus. Carcinogenesis 37, 223\u2013232. https:\/\/doi.org\/10.1093\/carcin\/bgw005 (2016).","journal-title":"Carcinogenesis"},{"key":"25904_CR27","doi-asserted-by":"publisher","first-page":"188607","DOI":"10.1016\/j.bbcan.2021.188607","volume":"1876","author":"A Kanakkanthara","year":"2021","unstructured":"Kanakkanthara, A. & Miller, J. H. betaIII-tubulin overexpression in cancer: Causes, consequences, and potential therapies. Biochim. Biophys. Acta Rev. Cancer. 1876, 188607. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188607 (2021).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"25904_CR28","doi-asserted-by":"publisher","unstructured":"Binarova, P., Tuszynski, J. & Tubulin Structure, functions and roles in disease. Cells 8 https:\/\/doi.org\/10.3390\/cells8101294 (2019).","DOI":"10.3390\/cells8101294"},{"key":"25904_CR29","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.bmc.2009.11.002","volume":"18","author":"WJ Moore","year":"2010","unstructured":"Moore, W. J. et al. Modulation of Wnt signaling through Inhibition of secreted frizzled-related protein I (sFRP-1) with N-substituted piperidinyl diphenylsulfonyl sulfonamides: Part II. Bioorg. Med. Chem. 18, 190\u2013201 (2010).","journal-title":"Bioorg. Med. Chem."},{"key":"25904_CR30","doi-asserted-by":"publisher","first-page":"488","DOI":"10.2174\/1871520617666171103140749","volume":"18","author":"KP Rakesh","year":"2018","unstructured":"Rakesh, K. P. et al. Recent development of sulfonyl or sulfonamide hybrids as potential anticancer agents: A key review. Anticancer Agents Med. Chem. 18, 488\u2013505. https:\/\/doi.org\/10.2174\/1871520617666171103140749 (2018).","journal-title":"Anticancer Agents Med. Chem."},{"key":"25904_CR31","doi-asserted-by":"publisher","unstructured":"Gonzalez, M. et al. Microtubule destabilizing sulfonamides as an alternative to taxane-based chemotherapy. Int. J. Mol. Sci. 22 https:\/\/doi.org\/10.3390\/ijms22041907 (2021).","DOI":"10.3390\/ijms22041907"},{"key":"25904_CR32","doi-asserted-by":"publisher","first-page":"111702","DOI":"10.1016\/j.ejmech.2019.111702","volume":"183","author":"B Zengin Kurt","year":"2019","unstructured":"Zengin Kurt, B. et al. Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies. Eur. J. Med. Chem. 183, 111702. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111702 (2019).","journal-title":"Eur. J. Med. Chem."},{"key":"25904_CR33","doi-asserted-by":"publisher","first-page":"6429","DOI":"10.1039\/d1sc01389k","volume":"12","author":"VT Nguyen","year":"2021","unstructured":"Nguyen, V. T. et al. Photocatalytic decarboxylative amidosulfonation enables direct transformation of carboxylic acids to sulfonamides. Chem. Sci. 12, 6429\u20136436. https:\/\/doi.org\/10.1039\/d1sc01389k (2021).","journal-title":"Chem. Sci."},{"key":"25904_CR34","doi-asserted-by":"publisher","first-page":"127108","DOI":"10.1016\/j.bmcl.2020.127108","volume":"30","author":"MA Ortiz","year":"2020","unstructured":"Ortiz, M. A. et al. Discovery of cyclic guanidine-linked sulfonamides as inhibitors of LMTK3 kinase. Bioorg. Med. Chem. Lett. 30, 127108. https:\/\/doi.org\/10.1016\/j.bmcl.2020.127108 (2020).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"25904_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11010-013-1872-7","volume":"387","author":"JS Kim","year":"2014","unstructured":"Kim, J. S. et al. MicroRNA-205 suppresses the oral carcinoma oncogenic activity via down-regulation of Axin-2 in KB human oral cancer cell. Mol. Cell. Biochem. 387, 71\u201379. https:\/\/doi.org\/10.1007\/s11010-013-1872-7 (2014).","journal-title":"Mol. Cell. Biochem."},{"key":"25904_CR36","doi-asserted-by":"publisher","first-page":"307","DOI":"10.4161\/epi.4.5.9371","volume":"4","author":"Y Ying","year":"2009","unstructured":"Ying, Y. & Tao, Q. Epigenetic disruption of the WNT\/beta-catenin signaling pathway in human cancers. Epigenetics 4, 307\u2013312 (2009).","journal-title":"Epigenetics"},{"key":"25904_CR37","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10689-014-9775-7","volume":"14","author":"S Li","year":"2015","unstructured":"Li, S., Wang, C., Liu, X., Hua, S. & Liu, X. The roles of AXIN2 in tumorigenesis and epigenetic regulation. Fam Cancer. 14, 325\u2013331. https:\/\/doi.org\/10.1007\/s10689-014-9775-7 (2015).","journal-title":"Fam Cancer"},{"key":"25904_CR38","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.bbrc.2013.11.089","volume":"443","author":"SA Rennoll","year":"2014","unstructured":"Rennoll, S. A., Konsavage, W. M. Jr. & Yochum, G. S. Nuclear AXIN2 represses MYC gene expression. Biochem. Biophys. Res. Commun. 443, 217\u2013222. https:\/\/doi.org\/10.1016\/j.bbrc.2013.11.089 (2014).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"25904_CR39","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1038\/s41467-019-12203-8","volume":"10","author":"DB Bernkopf","year":"2019","unstructured":"Bernkopf, D. B., Bruckner, M., Hadjihannas, M. V. & Behrens, J. An Aggregon in conductin\/axin2 regulates Wnt\/beta-catenin signaling and holds potential for cancer therapy. Nat. Commun. 10, 4251. https:\/\/doi.org\/10.1038\/s41467-019-12203-8 (2019).","journal-title":"Nat. Commun."},{"key":"25904_CR40","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41580-020-0214-3","volume":"21","author":"C Janke","year":"2020","unstructured":"Janke, C. & Magiera, M. M. The tubulin code and its role in controlling microtubule properties and functions. Nat. Rev. Mol. Cell. Biol. 21, 307\u2013326. https:\/\/doi.org\/10.1038\/s41580-020-0214-3 (2020).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"25904_CR41","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41580-021-00399-x","volume":"22","author":"NB Gudimchuk","year":"2021","unstructured":"Gudimchuk, N. B. & McIntosh, J. R. Regulation of microtubule dynamics, mechanics and function through the growing tip. Nat. Rev. Mol. Cell. Biol. 22, 777\u2013795. https:\/\/doi.org\/10.1038\/s41580-021-00399-x (2021).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"25904_CR42","doi-asserted-by":"publisher","first-page":"5980","DOI":"10.1038\/s41467-023-41615-w","volume":"14","author":"J Zhou","year":"2023","unstructured":"Zhou, J. et al. Structural insights into the mechanism of GTP initiation of microtubule assembly. Nat. Commun. 14, 5980. https:\/\/doi.org\/10.1038\/s41467-023-41615-w (2023).","journal-title":"Nat. Commun."},{"key":"25904_CR43","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature03566","volume":"435","author":"B Gigant","year":"2005","unstructured":"Gigant, B. et al. Structural basis for the regulation of tubulin by vinblastine. Nature 435, 519\u2013522. https:\/\/doi.org\/10.1038\/nature03566 (2005).","journal-title":"Nature"},{"key":"25904_CR44","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1126\/science.aat4100","volume":"360","author":"L Caputi","year":"2018","unstructured":"Caputi, L. et al. Missing enzymes in the biosynthesis of the anticancer drug vinblastine in Madagascar periwinkle. Science 360, 1235\u20131239. https:\/\/doi.org\/10.1126\/science.aat4100 (2018).","journal-title":"Science"},{"key":"25904_CR45","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1091\/mbc.E15-06-0453","volume":"27","author":"S Patnaik","year":"2016","unstructured":"Patnaik, S. et al. By moonlighting in the nucleus, Villin regulates epithelial plasticity. Mol. Biol. Cell. 27, 535\u2013548. https:\/\/doi.org\/10.1091\/mbc.E15-06-0453 (2016).","journal-title":"Mol. Biol. Cell."},{"key":"25904_CR46","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.bmc.2005.09.037","volume":"14","author":"L Bouissane","year":"2006","unstructured":"Bouissane, L. et al. Synthesis and biological evaluation of N-(7-indazolyl)benzenesulfonamide derivatives as potent cell cycle inhibitors. Bioorg. Med. Chem. 14, 1078\u20131088. https:\/\/doi.org\/10.1016\/j.bmc.2005.09.037 (2006).","journal-title":"Bioorg. Med. Chem."},{"key":"25904_CR47","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1021\/acs.jmedchem.6b01254","volume":"60","author":"CR Coxon","year":"2017","unstructured":"Coxon, C. R. et al. Cyclin-Dependent kinase (CDK) inhibitors: Structure-activity relationships and insights into the CDK-2 selectivity of 6-substituted 2-arylaminopurines. J. Med. Chem. 60, 1746\u20131767. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b01254 (2017).","journal-title":"J. Med. Chem."},{"key":"25904_CR48","doi-asserted-by":"publisher","first-page":"32607","DOI":"10.1021\/acsomega.1c04175","volume":"6","author":"TJ Fuhrer","year":"2021","unstructured":"Fuhrer, T. J., Houck, M., Iacono, S. T. & Fluoromaticity The molecular orbital contributions of fluorine substituents to the pi-systems of aromatic rings. ACS Omega. 6, 32607\u201332617. https:\/\/doi.org\/10.1021\/acsomega.1c04175 (2021).","journal-title":"ACS Omega"},{"key":"25904_CR49","doi-asserted-by":"publisher","first-page":"5368","DOI":"10.1021\/acs.chemmater.3c00556","volume":"35","author":"M Wang","year":"2023","unstructured":"Wang, M. et al. Fluorine-substituted donor\u2013acceptor covalent organic frameworks for efficient photocatalyst hydrogen evolution. Chem. Mater. 35, 5368\u20135377. https:\/\/doi.org\/10.1021\/acs.chemmater.3c00556 (2023).","journal-title":"Chem. Mater."},{"key":"25904_CR50","doi-asserted-by":"publisher","unstructured":"Radu, A. F. et al. Simulation-Based research on phytoconstituents of embelia Ribes targeting proteins with pathophysiological implications in rheumatoid arthritis. Life (Basel). 13 https:\/\/doi.org\/10.3390\/life13071467 (2023).","DOI":"10.3390\/life13071467"},{"key":"25904_CR51","doi-asserted-by":"publisher","first-page":"10629","DOI":"10.1080\/07391102.2021.1947384","volume":"40","author":"D Kashyap","year":"2022","unstructured":"Kashyap, D. et al. Plant derived active compounds as potential anti SARS-CoV-2 agents: An in-silico study. J. Biomol. Struct. Dyn. 40, 10629\u201310650. https:\/\/doi.org\/10.1080\/07391102.2021.1947384 (2022).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"25904_CR52","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/jcc.20945","volume":"29","author":"S Jo","year":"2008","unstructured":"Jo, S., Kim, T., Iyer, V. G. & Im, W. CHARMM-GUI: A web-based graphical user interface for CHARMM. J. Comput. Chem. 29, 1859\u20131865. https:\/\/doi.org\/10.1002\/jcc.20945 (2008).","journal-title":"J. Comput. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25904-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25904-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25904-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:54:45Z","timestamp":1764082485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25904-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25904"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-25904-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"21 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We have all read and approved the final version of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41858"}}